Post by Novotech

Behind every successful clinical program is scientific expertise that helps sponsors make confident development decisions. At Novotech, our scientific leaders work alongside sponsors to help shape development strategies, navigate regulatory pathways, and advance complex clinical programs from early-phase development through global execution. We’re proud to spotlight some of the experts helping advance innovative therapies globally: 🔹Alex Lai, MD, PhD, Senior Principal Consultant, End-to-End Drug Development 🔹Karen Scalzo-Inguanti PhD, Director, Drug Development Consulting & Early Phase Specialist 🔹Steven Cha, MD, Therapeutic Strategy Lead, Oncology 🔹Tanja Obradovic, PhD, Therapeutic Strategy Lead, Oncology 🔹Tom Hickey, Director, Therapeutic Strategy, Infectious Diseases and Immunology 🔹Carolyn Luscombe, PhD, Manager, Therapeutic Strategy, Early Phase Learn more about the team: https://lnkd.in/eAxrAh9a #ClinicalTrials #DrugDevelopment